ESR Connect

    Special Focus Session

    SF 23 - Imaging answers to immunotherapy demands

    • ECR 2025
    • 5 Lectures
    • 90 Minutes
    • 4 Speakers

    Lectures

    1
    Chairperson's introduction

    Chairperson's introduction

    05:00Mirjam Gerwing, Münster / DE

    2
    Why bother: oncologist's issues with immunotherapy

    Why bother: oncologist's issues with immunotherapy

    25:00Carolin Lips, St. Gallen / CH

    3
    Cellular heterogeneity in MRI

    Cellular heterogeneity in MRI

    25:00Mirjam Gerwing, Münster / DE, Emily Hoffmann, Münster / DE

    4
    Immuno-PET: FAPI and beyond

    Immuno-PET: FAPI and beyond

    25:00Frederik L. Giesel, Düsseldorf / DE

    5
    Panel discussion: What is needed in clinical routine? How can imaging aid immunotherapy?

    Panel discussion: What is needed in clinical routine? How can imaging aid immunotherapy?

    10:00Panel discussion: What is needed in clinical routine? How can imaging aid immunotherapy?

    Description

    5 min
    Chairperson's introduction
    Mirjam Gerwing, Münster / Germany
    25 min
    Why bother: oncologist's issues with immunotherapy
    Carolin Lips, St. Gallen / Switzerland
    1. To appreciate the challenges oncologists face when treating patients with immunotherapy.
    2. To learn that differentiation of progression and pseudoprogression needs advanced imaging.
    3. To understand that inter- and intratumoural heterogeneity needs precise imaging for individual patient care.
    25 min
    Cellular heterogeneity in MRI
    Mirjam Gerwing, Münster / Germany
    Emily Hoffmann, Münster / Germany
    1. To learn the basic principles of high-resolution proton MR spectroscopic imaging (1H - MRSI) and sodium imaging (23Na MRI) in ultrastructural tumour evaluation.
    2. To understand the added value of 1H - MRSI and 23Na MRI compared to conventional MRI in monitoring patients under immunotherapy.
    3. To understand how sodium concentration changes in 23Na MRI and the activity of different metabolites in 1H MRSI relate to response to tumour immunotherapy.
    25 min
    Immuno-PET: FAPI and beyond
    Frederik L. Giesel, Düsseldorf / Germany
    1. To understand the principles of FAPI-PET and its application in patients treated with immunotherapy.
    2. To learn how advances in hybrid imaging enable precise staging and evaluation of therapy response.
    3. To appreciate future possibilities in hybrid imaging that might come after FAPI.
    10 min
    Panel discussion: What is needed in clinical routine? How can imaging aid immunotherapy?

    This session offers AI-generated subtitles.

    Categories and Tags

    Moderators

    • Mirjam Gerwing

      Münster / Germany

    Speakers

    • Mirjam Gerwing

      Münster / Germany

    • Carolin Lips

      St. Gallen / Switzerland

    • Emily Hoffmann

      Münster / Germany

    • Frederik L. Giesel

      Düsseldorf / Germany